新用途的问题。 - Suppr

Suppr

超能文献

The problem of new uses.

作者信息

Eisenberg Rebecca S

机构信息

University of Michigan Law School, USA.

出版信息

Yale J Health Policy Law Ethics. 2005 Summer;5(2):717-39.

PMID:16052897

Abstract

摘要

相似文献

The problem of new uses.

Yale J Health Policy Law Ethics. 2005 Summer;5(2):717-39.

Regulatory paternalism in the market for drugs: lessons from Vioxx and Celebrex.

Yale J Health Policy Law Ethics. 2005 Summer;5(2):741-70.

The vexations of Vioxx.

CMAJ. 2006 Feb 14;174(4):444-5. doi: 10.1503/cmaj.060041.

Raising the safety bar--the FDA's coxib meeting.

N Engl J Med. 2005 Mar 31;352(13):1283-5. doi: 10.1056/NEJMp058055.

Withdrawal syndrome.

Nat Med. 2004 Nov;10(11):1143. doi: 10.1038/nm1104-1143.

New use approved for Vioxx.

FDA Consum. 2002 Jul-Aug;36(4):3.

Painkiller in the dock.

Nature. 2005 Jul 28;436(7050):459. doi: 10.1038/436459a.

Learning the value of drugs--is rofecoxib a regulatory success story?

N Engl J Med. 2005 Mar 31;352(13):1285-7. doi: 10.1056/NEJMp048358.

How to avoid another 'Vioxx'.

Nat Rev Drug Discov. 2005 Jan;4(1):5-7. doi: 10.1038/nrd1629.

Vioxx doctors wooed by Merck are now its foes.

Wall St J (East Ed). 2006 Mar 10:B1, B3.

引用本文的文献

Repurposing existing drugs for new uses: a cohort study of the frequency of FDA-granted new indication exclusivities since 1997.

J Pharm Policy Pract. 2021 Jan 4;14(1):3. doi: 10.1186/s40545-020-00282-8.

Do firms underinvest in long-term research? Evidence from cancer clinical trials.

Am Econ Rev. 2015 Jul;105(7):2044-2085. doi: 10.1257/aer.20131176.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

The problem of new uses.

Yale J Health Policy Law Ethics. 2005 Summer;5(2):717-39.

Regulatory paternalism in the market for drugs: lessons from Vioxx and Celebrex.

Yale J Health Policy Law Ethics. 2005 Summer;5(2):741-70.

The vexations of Vioxx.

CMAJ. 2006 Feb 14;174(4):444-5. doi: 10.1503/cmaj.060041.

Raising the safety bar--the FDA's coxib meeting.

N Engl J Med. 2005 Mar 31;352(13):1283-5. doi: 10.1056/NEJMp058055.

Withdrawal syndrome.

Nat Med. 2004 Nov;10(11):1143. doi: 10.1038/nm1104-1143.

New use approved for Vioxx.

FDA Consum. 2002 Jul-Aug;36(4):3.

Painkiller in the dock.

Nature. 2005 Jul 28;436(7050):459. doi: 10.1038/436459a.

Learning the value of drugs--is rofecoxib a regulatory success story?

N Engl J Med. 2005 Mar 31;352(13):1285-7. doi: 10.1056/NEJMp048358.

How to avoid another 'Vioxx'.

Nat Rev Drug Discov. 2005 Jan;4(1):5-7. doi: 10.1038/nrd1629.

Vioxx doctors wooed by Merck are now its foes.

Wall St J (East Ed). 2006 Mar 10:B1, B3.

引用本文的文献

Repurposing existing drugs for new uses: a cohort study of the frequency of FDA-granted new indication exclusivities since 1997.

J Pharm Policy Pract. 2021 Jan 4;14(1):3. doi: 10.1186/s40545-020-00282-8.

Do firms underinvest in long-term research? Evidence from cancer clinical trials.

Am Econ Rev. 2015 Jul;105(7):2044-2085. doi: 10.1257/aer.20131176.